相关实验视频

Updated: May 12, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [¹⁸F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

患者和护理人员对CAR T细胞治疗的经验:定性分析

Maija Reblin¹, Irene Liang², Djin L Tay³

¹Department of Family Medicine, University of Vermont, Burlington, VT, USA.

Journal of psychosocial oncology

|January 30, 2025

概括

卡特-T疗法需要密集的护理人员支持,影响患者和家人身体和关系. 成本和物流等社会因素也使这种新的癌症治疗体验变得复杂.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
患者护理患者护理

背景情况:

化学抗原受体T细胞 (CAR-T) 疗法为某些癌症提供了新的希望.
在注射后,CAR-T治疗需要大量的家庭护理人员参与.
了解患者和护理人员对CAR-T的体验是非常重要的,因为它是新的.

研究的目的:

探索接受CAR-T治疗的患者及其护理人员的实践经验.
确定患者和护理人员在CAR-T治疗过程中所面临的关键主题和挑战.

主要方法:

定性研究涉及与CAR-T患者及其护理人员进行半结构面试.
采访成绩单的分析,以双癌症结局框架为指导.
诱导性主题分析,以确定患者和护理人员经验中的反复模式.

主要成果:

出现了三个主要主题:个人 (身体/心理社会影响),关系 (照顾者对关系的压力) 和情境 (社会/金融挑战).
卡特治疗显著影响了患者和护理人员的福祉.
退院后护理的密集,孤立的性质加剧了患者和护理人员关系的动态.

结论:

患者和护理人员的CAR-T体验与其他癌症治疗有相似之处,但由于不断的护理需求而加剧.
住房,旅行和财务等社会决定因素带来了重大障碍.
开发以家庭为中心的支持计划对于优化CAR-T治疗结果至关重要.

关键词:

在CART-T中,我们可以使用CAR-T.提供护理提供护理迪亚德 (Dyad) 迪亚德 (Dyad) 是一个词.免疫疗法免疫疗法瘤学在瘤学方面.

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...